U.S. Markets closed

Synairgen plc (SNG.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
220.00+14.00 (+6.80%)
At close: 4:35PM BST

Synairgen plc





Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees14

Key Executives

NameTitlePayExercisedYear Born
Mr. Richard MarsdenCEO, MD & Exec. Director289kN/A1968
Mr. John WardFin. Director, Company Sec. & Exec. Director226kN/A1962
Dr. Phillip David MonkChairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director208kN/A1969
Prof. Donna DaviesCo-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Prof. Ratko DjukanovicCo-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Corporate Governance

Synairgen plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.